Phase 3 Graves Ophthalmopathy Clinical Trials

2 recruitingPhase 3

What is a Phase 3 trial?

Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.

Showing 1–2 of 2 trials

Recruiting

Phase 2Phase 3

Extension Study of Two Doses of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED)

Thyroid DiseasesEndocrine System DiseasesThyroid Eye Disease+9 more

Sling Therapeutics, Inc.75 enrolled2 locationsNCT06112340

Recruiting

Phase 3

Treatment of Graves´ophthalmopathy with Simvastatin (GO-S)

Thyroid Associated OphthalmopathyGraves OphthalmopathyThyroid Associated Orbitopathy

Lund University80 enrolled1 locationNCT03131726